Mydriacyl (Tropicamide)

Tropicamide, the active ingredient in Mydriacyl, is an antimuscarinic (muscarinic antagonist) presented as an ophthalmic solution for ocular use. It produces reversible pupil dilation and temporary paralysis of the ciliary muscle to facilitate eye examinations and diagnostic procedures.

GNH USA supplies Mydriacyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Tropicamide is used as a mydriatic and cycloplegic agent in ophthalmic practice.

- Diagnostic eye examination: provides pupil dilation to allow thorough inspection of the retina and optic nerve. - Refraction testing: induces cycloplegia to temporarily paralyze accommodation, facilitating accurate measurement of refractive errors. - Pre‑operative ocular assessment: creates a stable, dilated pupil for procedures such as laser therapy or intra‑ocular surgery planning.

Tropicamide may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Blurred vision: temporary loss of near focus due to cycloplegia. - Photophobia: increased light sensitivity from pupil dilation. - Eye discomfort or stinging: mild irritation upon instillation. - Transient increase in intra‑ocular pressure: usually short‑lived.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: rapid rise in intra‑ocular pressure requiring emergency care. - Severe allergic reaction: including rash, swelling, or anaphylaxis. - Persistent mydriasis: prolonged pupil dilation beyond expected duration. - Systemic anticholinergic effects: dry mouth, tachycardia, or confusion, especially in susceptible patients.

Before using Mydriacyl, consider the following precautions.

- Assess intra‑ocular pressure: avoid in patients with narrow‑angle glaucoma. - Screen for hypersensitivity: discontinue immediately if allergic signs appear. - Use lowest effective concentration: limit systemic absorption. - Avoid concurrent ocular anticholinergics: may amplify mydriasis and cycloplegia. - Store at room temperature: keep in the original container, protect from light and moisture.

Tropicamide can interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Other ocular anticholinergics: additive mydriasis and cycloplegia. - Systemic anticholinergic drugs: increased overall anticholinergic burden. - Monoamine oxidase inhibitors: potential enhancement of ocular pressure changes. - Adrenergic agonists: unpredictable pupil response.

Moderate Interactions (Monitor Closely): - Topical beta‑blockers: may affect intra‑ocular pressure control. - Other cycloplegic agents (e.g., atropine): overlapping effects require dose adjustment. - Systemic antihistamines: may increase ocular dryness and discomfort.